- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/45 - Non-condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
Patent holdings for IPC class A61K 31/45
Total number of patents in this class: 535
10-year publication summary
|
20
|
32
|
48
|
55
|
42
|
38
|
42
|
41
|
45
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Celgene Corporation | 1468 |
20 |
| Amicus Therapeutics, Inc. | 354 |
19 |
| Dana-Farber Cancer Institute, Inc. | 2535 |
11 |
| Boehringer Ingelheim International GmbH | 4754 |
9 |
| Bristol-myers Squibb Company | 4863 |
8 |
| Amgen Inc. | 3899 |
7 |
| Novartis AG | 11254 |
6 |
| The Regents of the University of California | 19517 |
6 |
| Bpcr Limited Partnership | 38 |
6 |
| Allergan, Inc. | 2438 |
5 |
| Baylor College of Medicine | 917 |
5 |
| Cambridge Enterprise Limited | 1148 |
5 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 896 |
5 |
| F. Hoffmann-La Roche AG | 7942 |
4 |
| The Johns Hopkins University | 5533 |
4 |
| Eli Lilly and Company | 3720 |
4 |
| Epizyme, Inc. | 386 |
4 |
| Obschestvo S Ogranichennoi Otvetstvennostiyu "pharmenterprises" | 33 |
4 |
| Queen's University at Kingston | 534 |
4 |
| University of Saskatchewan | 470 |
4 |
| Other owners | 395 |